Co-Authors
This is a "connection" page, showing publications co-authored by Viswanathan Palanisamy and Mrinmoyee Majumder.
Connection Strength
3.610
-
HuR as a molecular target for cancer therapeutics and immune-related disorders. Adv Drug Deliv Rev. 2022 09; 188:114442.
Score: 0.795
-
Compendium of Methods to Uncover RNA-Protein Interactions In Vivo. Methods Protoc. 2021 Mar 19; 4(1).
Score: 0.726
-
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. Crit Rev Biochem Mol Biol. 2020 10; 55(5):409-424.
Score: 0.699
-
RNA binding protein FXR1-miR301a-3p axis contributes to p21WAF1 degradation in oral cancer. PLoS Genet. 2020 01; 16(1):e1008580.
Score: 0.669
-
RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC. PLoS Genet. 2016 09; 12(9):e1006306.
Score: 0.531
-
Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer. PLoS One. 2018; 13(10):e0205077.
Score: 0.153
-
Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nat Commun. 2017 11 16; 8(1):1534.
Score: 0.036